Insights

Intellectual Property Intellectual Property

Type (0)

Results

All Insights

Osler Update June 24, 2016

Privilege for patent and trademark agents now in force in Canada

This new statutory privilege represents a significant improvement to Canada's intellectual property regime. Learn more.

Read more
Osler Update June 7, 2016

Federal Court continues to breathe life into motions to dismiss proceedings under the Patented Medicines (Notice of Compliance) Regulations

In amended reasons released on May 26, 2016, the Federal Court in Janssen Inc. v. Celltrion Healthcare Co. Ltd. granted a motion to dismiss an...

Read more
Osler Update June 6, 2016

$125-million pharmaceutical damages award undone by hearsay rule

The Court questioned Teva’s ability to supply the market due to its reliance on inadmissible hearsay evidence. The judgment is expected to have...

Read more
Osler Update June 1, 2016

Federal Court limits number of experts to five per side for all phases of a proceeding

This ruling, which may still be appealed, may lower litigation costs in more complex proceedings, but it will require parties to select and marshal...

Read more
Osler Update April 4, 2016

Revised Intellectual Property Enforcement Guidelines clarify the Competition Bureau’s approach in IP matters

Last week, the Competition Bureau released revised Intellectual Property Enforcement Guidelines after engaging in a lengthy consultation period based...

Read more
Osler Update January 25, 2016

Drug Licensees Subject To Federal Price Regulation In Canada – Law360

Canada has long regulated the price of patented pharmaceutical products with the intent to protect consumers from excessive prices. In recent years,...

Read more